Polycystic ovary syndrome and adipose tissue

M Lemaitre, S Christin-Maitre, V Kerlan - Annales d'endocrinologie, 2023 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common endocrine metabolic disorder in
women of reproductive age. Typically, it is associated with ovulatory dysfunction …

Psychological symptoms and brain activity alterations in women with PCOS and their relation to the reduced quality of life: a narrative review

J Pinto, N Cera, D Pignatelli - Journal of Endocrinological Investigation, 2024 - Springer
Background Polycystic ovary syndrome (PCOS) is the most common feminine endocrine
disorder, characterized by androgen excess, ovulatory dysfunction, and polycystic ovarian …

Approach the patient with obstructive sleep apnea and obesity

EJ Meyer, GA Wittert - The Journal of Clinical Endocrinology & …, 2024 - academic.oup.com
Obstructive sleep apnea (OSA) and obesity are highly prevalent and bidirectionally
associated. OSA is underrecognized, however, particularly in women. By mechanisms that …

Polycystic ovary syndrome in obstructive sleep apnea-hypopnea syndrome: an updated meta-analysis

J He, X Ruan, J Li - Frontiers in Endocrinology, 2024 - frontiersin.org
Background Obstructive sleep apnea-hypopnea syndrome (OSAHS) is correlated with
metabolic deterioration in patients experiencing polycystic ovary syndrome (PCOS). Women …

Evaluation of daytime sleepiness and insomnia symptoms in OSA patients with a characterization of symptom-defined phenotypes and their involvement in depression …

A Gabryelska, S Turkiewicz, P Białasiewicz… - Frontiers in …, 2024 - frontiersin.org
Introduction Recent research highlights the significance of insomnia and sleepiness, shifting
from obstructive sleep apnea (OSA) severity and sleep structure, in defining OSA …

[HTML][HTML] Visceral Adiposity Index as an Indicator for Menstrual Disturbance, Hormonal and Metabolic Dysfunction in Polycystic Ovarian Syndrome

P Sharma, A Sarkar, H Kaur, U Gupta, B Kumar - Cureus, 2022 - ncbi.nlm.nih.gov
Background: Increase in visceral adiposity is characteristic of polycystic ovarian syndrome
(PCOS) and is the main cause of insulin resistance and hyperandrogenism. This study tried …

Comorbidities in women with polycystic ovary syndrome: a sibling study

BV Boldis, I Grünberger, A Cederström, J Björk… - BMC Women's …, 2024 - Springer
Background Polycystic ovary syndrome (PCOS) has previously been associated with
several comorbidities that may have shared genetic, epigenetic, developmental or …

Alternatives to Antibiotics GOAL: ELEVATING Antibiotic Resistance During the Post-COVID Period

S Kabiri-Samani, M Sanatgaran… - Personalized Medicine …, 2022 - pmjournal.ir
The COVID-19 outbreak offers an unmatched chance to take advantage of personalized
medicine's benefits for the protection, detection, medication, monitoring, and administration …

Beyond Counting Sheep: Exploring the Link between Polycystic Ovary Syndrome and Sleep Health

NKA Jafar, CJ Bennett, LJ Moran… - Seminars in …, 2023 - thieme-connect.com
Polycystic ovary syndrome (PCOS) is a common hormonal condition with reproductive,
metabolic, and psychological sequelae that affects 8 to 13% of reproductive-aged women …

The role of obstetrician-gynecologists and reproductive endocrinologists in the blood glucose management of polycystic ovary syndrome

Y Wang, R Ma, Y Zou, W Wang, Q Zheng… - Gynecological …, 2022 - Taylor & Francis
Background: This study aimed to compare the differences between reproductive
endocrinologists (Repro-Endo) and obstetricians-gynecologists (Ob-Gyn; non-reproductive …